Vident Advisory, LLC Corcept Therapeutics Inc Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 186,020 shares of CORT stock, worth $8.45 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
186,020
Previous 182,419
1.97%
Holding current value
$8.45 Million
Previous $4.6 Billion
31.53%
% of portfolio
0.17%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding CORT
# of Institutions
311Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$751 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$434 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$374 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$314 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$173 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $4.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...